WASHINGTON, DC (NV) – Two drug companies Lupine Pharmaceuticals and Teligent Pharma recently announced the need to recall two drugs, according to the Food and Drug Administration (FDA).
On October 14, Lupine announced it needed to recall Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets, which are used to treat blood pressure and symptoms of type 2 diabetes.
Lupine said the drug had to be recalled because of excess levels of N-nitrosoirbesartan.
Between October 8, 2018, and September 30, 2021, Lupine received four reports of illness associated with Irbesartan and none related to Irbesartan and Hydrochlorothiazide.
As a precaution, the pharmaceutical company is recalling all shipments of Irbesartan Tablets USP 75mg, 150mg and 300mg and Irbesartan and Hydrochlorothiazide Tablets USP 150mg/12.5mg and 300mg/12.5mg in the US.
Lupine discontinued production of Irbesartan and Irbesartan HCTZ from January 2021.
On September 3, Teligent announced a recall of the anesthetic Lidocaine HCI Topical Solution 4% due to the risk that a higher-than-expected dose of lidocaine could cause local anesthetic toxicity, worsen illness or even death. The product to be recalled is sold in 50ml bottles with screw caps. (Th.Long)
The post The recall of Lupine’s blood pressure medication and Teligent’s anesthetic first appeared on Nguoi Viet Online.